logo-loader
LON:RENE

ReNeuron Group PLC

Receive alerts
Market:
LON
Market Cap:
£67.19 m
Price
£2.11
Change
6.34%
52 weeks high
342.00
52 weeks low
29.50

In brief

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.